WILMINGTON, Del., June 19, 2007 (PRIME NEWSWIRE) -- Rx Processing Corporation (Pink Sheets:RXPC), a source of low-cost prescription medications and diagnostic laboratory tests for millions of Americans announces the board of directors declares on June 19, 2007, an additional stock dividend to be paid August 10, 2007 to all shareholders.
Rx Processing Corp. shareholders will receive 10 shares of Rx Processing Corp. for every 100 shares held on the record date of July 6, 2007.
Chairman Peter Fiorillo stated, "The issuing of common stock dividends can be expected to increase as we maintain RXPCs commitment to its shareholders. I am changing the company's strategy by canceling the 15 million share retirement announced in February to a strategy of rewarding our existing shareholders by increasing their common share positions."
O/S: 63,790,891 Float: 26,181,836 Shareholders: 473
Rx Processing Corp., an innovator in the distribution of pharmaceutical medications and laboratory diagnostics managed through storefront locations, is deploying a direct to consumer delivery business model that fulfills the needs of under and uninsured clients' health care needs. The company provides access to FDA approved brand-name and generic medications, thousands of laboratory diagnostics with access to 4,000+ CLIA-certified patient service centers for specimen collection. Rx Processing Corp. estimates that more than 48 million United States citizens would benefit from these company programs.
Safe Harbor Statement:
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including those about the company's future expectations, revenues and earnings, and all other forward-looking statements (i.e. operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.